Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital
1 other identifier
observational
20
1 country
1
Brief Summary
Clinical Characteristics and Risk factors of Children Suffering from Inflammatory Bowel Diseases At Assiut University Children Hospital
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2021
CompletedStudy Start
First participant enrolled
August 5, 2021
CompletedFirst Posted
Study publicly available on registry
August 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 20, 2027
August 12, 2021
July 1, 2021
6 years
July 20, 2021
August 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical characteristics and risk factors for IBD
To study the natural history, patterns, and clinical characteristics (as history of real bleeding, mucus or blood in the stool, diarrhea, abdominal pain ,vomiting)and risk factors of inflammatory bowel diseases (IBD) at Assiut University Children Hospital
6 months
Study Arms (1)
Children aged less than 18 years with a confirmed diagnosis of IBD.
All patients admitted with inflammatory bowel disease will be subjected to: 1. History: including name, age ,sex ,family history, consanguinity, history of rectal bleeding, mucus or blood in the stool, diarrhea, abdominal pain ,vomiting ,nausea and loss of appetite. 2. Examination: including general examination, chest, cardiac, abdominal and neurological examination 3. Investigation:including labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.
Interventions
labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.
Eligibility Criteria
All patients admitted with inflammatory bowel disease
You may qualify if:
- \- Children aged less than 18 years with a confirmed diagnosis of IBD.
You may not qualify if:
- Children with colitis other than IBD or children with systemic diseases affecting GIT.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Christine zaghloul noos
Asyut, 23123, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shereen Mansour, Lecturer
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
July 20, 2021
First Posted
August 12, 2021
Study Start
August 5, 2021
Primary Completion (Estimated)
July 20, 2027
Study Completion (Estimated)
July 20, 2027
Last Updated
August 12, 2021
Record last verified: 2021-07